Lysosomal Disease Management and COVID-19

Scroll to the bottom of this page to obtain CME/CE credit

Lysosomal & Rare Disorders Research & Treatment Center

GRIDS-2020

August 01, 2020 – July 31, 2021

Lysosomal Disease Management and COVID-19

Continuing Education Information

This continuing education activity is provided through collaboration between Lysosomal and Rare Disorders Research and Treatment Center (LDRTC), CheckRare, and AffinityCE. This activity provides continuing education credit for Physicians, Physician Assistants, Nurses and Nurse Practitioners, as well as a statement of participation for other attendees.

Faculty

Ari Zimran, MD, Director of the Gaucher Clinic, Shaare Zedek Medical Center in Jerusalem, Israel

Uma Ramaswami, MD, Consultant in Inherited Metabolic Disorders, Lysosomal Disorders Unit, Royal Free London Hospital

Ozlem Goker-Alpan, MD, Founder and President Lysosomal & Rare Disorders Research & Treatment Center, Inc

Learning Outcomes

At the end of this activity, participants should be able to:

  • Identify the impact of COVID-19 pandemic on patients with Gaucher disease
  • Share practice of lysosomal disorders patient management during the COVID-19 pandemic lockdown/shielding period
  • Evaluate challenges for long term follow up of patients with LSDs and COVID -19 infections
  • Identify potential complications and secondary health issues

Disclosures

AffinityCE staff, LDRTC staff, and planning and review committees have no financial interests to disclose and do not recommend the use of products outside of the FDA approved labelling.

Conflict of interest for Dr. Ari Zimran was resolved through peer review of content by a non-conflicted reviewer.

Faculty Disclosures

Ari Zimran, MD
Takeda, Pfizer, Bio-events: Honoraria
Takeda, Prevail Therapeutics, AvroBio: Consultant
Research Grants: Takeda, Centogene and Pfizer
Provisional patent sharing on the combination of Ambroxol and glucocerebroside for PD prevention and treatment and additional indications

Physicians

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of AffinityCE and the LDRTC. AffinityCE is accredited by the ACCME to provide continuing medical education for physicians.

AffinityCE designates this enduring activity for a maximum of 1.5 hours of AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Physician Assistants

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of AffinityCE and the LDRTC. AffinityCE is accredited by the ACCME to provide continuing medical education for physicians.

AffinityCE designates this enduring activity for a maximum of 1.5 hours of AMA PRA Category 1 Credit™. Physician Assistants should claim only the credit commensurate with the extent of their participation in the activity.

Nurses

Continuing Nursing Education is provided for this program through the joint providership of AffinityCE and the LDRTC. AffinityCE is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation (ANCC). This activity provides a maximum of 1.5 hours of continuing nursing education credit.

Nurse Practitioners

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of AffinityCE and the LDRTC. AffinityCE is accredited by the ACCME to provide continuing medical education for physicians.

AffinityCE designates this enduring activity for a maximum of 1.5 hours of AMA PRA Category 1 Credit™. Nurse practitioners should claim only the credit commensurate with the extent of their participation in the activity.

Other Professionals

All other health care professionals completing this continuing education activity will be issued a Statement of participation indicating the number of hours of continuing education credit. This may be used for professional education CE credit. Please consult your accrediting organization or licensing board for their acceptance of this CE activity.

Commercial Support

No commercial support was provided for this activity.

Participation Costs

There is no cost to participate in these CE sessions.

CME Inquiries

For all CME policy-related inquiries, please contact us at ce@affinityced.com.
Send customer support requests to cds_support+ldrtc@affinityced.com.

How to Earn CE Credit

Lysosomal Disease Management and COVID-19
  1. Go to the following Web site: ldrtc.cds.pesgce.com
  2. Select the activity: Lysosomal Disease Management and COVID-19
  3. Enter an e-mail address and password to begin setting up your profile. Select “I Forgot My Password” if you need to reset the password you set up.
  4. Verify, correct, or add your information.
  5. Proceed and complete the activity evaluation and post-test for each activity.
  6. Upon completing your evaluations and post-test, you can download your CE certificate. Your CE record will also be stored here for later retrieval.
  7. You can return to the site at any time to print your certificate.

Please send any customer service requests to cds_support+ldrtc@affinityced.com.

  • Sign up
Lost your password? Please enter your username or email address. You will receive a link to create a new password via email.
We do not share your personal details with anyone.